|
 |
| |
| Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts |
|
| |
In-vivo Data
:
| Date | Ref. No. | Patent No. | Title | | 11/21/2012 | E-256-1999/0 | 7,659,081
7,993,857 | Methods for Measuring Adrenomedullin and Monitoring and Treating Adrenomedullin-mediated Diseases, Such as Diabetes and Cancer | | 11/1/2012 | E-249-2005/0 | 7,989,501
8,273,797 | Methods of Treating and Preventing Renal Cancer using Dimethane Sulfonate Compounds | | 10/26/2012 | E-196-2000/0 | 7,754,676
7,915,040
8,084,250 | Chimeric Defensin Proteins for Cancer Vaccines | | 10/6/2012 | E-177-2006/0 | 7,553,936 | New Target for the Treatment of Cancer, Infectious Diseases, Cardiac Diseases, and Platelet-Associated Disorders | | 8/1/2012 | E-318-2007/0 | 7,989,630 | Radiotracers for Imaging P-glycoprotein Transporter Function | | 3/2/2012 | E-160-2006/0 | 8,008,316 | Potent, Easy to Use Targeted Toxins as Anti-Tumor Agents | | 2/13/2012 | E-202-2008/0 | | A Novel Treatment for Malarial Infections | | 8/22/2011 | E-158-2009/0 | | 15kD Granulysin for Monocyte Differentiation: A New Immunotherapeutic for Both in vivo and ex vivo Applications | | 6/30/2011 | E-150-2007/0 | | A Novel Therapeutic Strategy for the Treatment of Hyperpigmentation and Melanoma | | 6/16/2011 | E-289-1999/0 | 6,664,263 | Imidazoacridones with Anti-Tumor Activity | | 6/1/2011 | E-118-2009/0 | | Novel Diagnostic and Therapeutic Biomarkers for Squamous Cell Carcinomas | | 2/28/2011 | E-296-2001/0 | 7,541,040 | Alleviating Symptoms of Th2-Like Cytokine Mediated Disorders by Reducing IL-13 Receptor-Expressing Cells in the Respiratory Tract | | 2/7/2011 | E-234-2008/2 | | Method for Predicting and Detecting Tumor Metastasis | | 10/29/2010 | E-265-1999/2 | 7,871,981 | Inhibition of Cell Motility, Angiogenesis and Metastasis | | 6/16/2010 | E-158-2005/0 | 8,378,071 | Identification of H2-Db and HLA-A2 Specific CD8 Epitopes from Human KDR/VEGFR-2 that Inhibit Angiogenesis by Vaccination | | 6/16/2010 | E-132-1988/0 | | Use of 8-C1-cAMP as Anticancer Drug | | 6/16/2010 | E-143-1996/0 | 6,413,544
6,770,291
7,001,614
7,288,266 | Novel DNA Liposome Complexes for Increased Systemic Delivery and Gene Expression | | 6/16/2010 | E-095-2000/2 | | Amelioration of Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors | | 6/16/2010 | E-009-1991/0
E-009-1991/1
E-301-1998/2 | 5,565,424 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists | | 6/16/2010 | E-137-2005/0 | | Methods and Compositions for Treating FUS1 Related Disorders | | 6/16/2010 | E-254-2005/2 | | Improved Interleukin Expression for Immunogenic Compositions and Vaccine Adjuvant | | 6/16/2010 | E-200-2005/0 | | Insect Cell Production of Recombinant Adeno-Associated Virus that Produce Cytotoxic Gene Products and Applications for Solid Tumor Therapy | | 6/16/2010 | E-295-2005/0 | | Novel Treatments for Autoimmune Neuroinflammatory Diseases including Multiple Sclerosis | | 6/16/2010 | E-070-2007/2 | | Human Cancer Therapy Using Engineered Anthrax Lethal Toxin | | 6/16/2010 | E-074-1999/2 | | Cyanovirins and Related Conjugates, Compositions, Nucleic Acids, Vectors, Host Cells, Methods of Production and Methods of Use for Microbicide Development | | 6/16/2010 | E-271-2006/0 | 8,258,278 | A Novel DNA Vaccine for the Treatment of Malignancies Expressing Immature Laminin Receptor Protein | | 6/16/2010 | E-294-2005/1 | | A Neuronal Avalanche Size (NAS) Assay to Screen for Cognitive Enhancers and Anti-Epileptics | | 6/16/2010 | E-286-2006/2 | 8,133,859 | A Novel Growth Factor and Anti-Apoptotic Agent for Promoting Lung Development and Treating Lung Disease | | 6/16/2010 | E-110-2006/0 | | Muramyl Dipeptide as a Therapeutic Agent for Inflammation | | 6/16/2010 | E-095-2008/0 | | A Prophylactic and Therapeutic for Preventing and Treating Tularemia by Rapid Activation of Host Cells and Antigen Recognition | | 6/16/2010 | E-227-2006/5 | 8,236,313 | Methods of Preventing Tissue Ischemia | | 6/16/2010 | E-182-2008/0 | 8,222,225 | Method of Treating Pneumoconiosis with Oligodeoxynucleotides | | 6/16/2010 | E-278-2007/0 | | Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy | | 6/16/2010 | E-086-2007/0 | 8,303,960 | An Imaging Radiotracer for the Noninvasive Detection of HER2-positive Tumors | | 6/16/2010 | E-079-2003/1 | 8,380,280 | Non-Invasive in vivo MRI Axon Diameter Measurement Methods | | 6/16/2010 | E-092-2008/0 | | Novel Oligonucleotides for Treatment of Human Cancer | | 6/16/2010 | E-074-1999/0
E-074-1999/1
E-074-1999/2
E-074-1999/3
E-117-1995/0
E-117-1995/1
E-198-2006/0 | 5,821,081
5,843,882
5,962,653
5,962,668
5,998,587
6,015,876
6,245,737
6,420,336
6,428,790
6,586,392
6,743,577
6,780,847
6,987,096
7,048,935
7,105,169
7,339,037
7,754,420 | The Protein Cyanovirin Inactivates HIV and Influenza | | 6/16/2010 | E-552-1982/2 | 6,998,252
7,015,024
7,045,136
7,045,313 | Recombinant Vaccines Based on Poxvirus Vectors | | 6/16/2010 | E-012-1999/0
E-089-1998/0
E-110-1993/0
E-178-1996/0
E-179-1996/0
E-196-1997/0
E-257-2000/0 | 5,688,501
7,163,818
7,332,307 | Therapeutic Antibacterial Applications of Phage | | 6/16/2010 | E-156-2009/0 | | Antibody Composition and Methods for the Prevention and Treatment of Lupus Nephritis | | 6/16/2010 | E-263-2009/0 | | Small-Molecule Inhibitors of Angiogenesis | | 6/16/2010 | E-217-2001/0
E-264-1997/0 | 6,685,949
7,641,906 | Moraxella Catarrhalis Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections | | 6/16/2010 | E-217-2001/0
E-228-1995/1 | 6,207,157
6,607,725
7,641,906 | Nontypeable Haemophilus Influenzae Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections | | 6/16/2010 | E-184-2001/1 | | Modified Growth Hormone | | 6/16/2010 | E-051-2002/1 | | Methods for Using Modulators of Extracellular Adenosine or an Adenosine Receptor to Enhance Immune Response and Inflammation | | 6/16/2010 | E-323-2000/0 | 7,723,111 | Activated Dual Specificity Lymphocytes and Their Methods of Use | | 6/16/2010 | E-121-2002/0 | 7,572,828 | Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid | | 6/16/2010 | E-275-2002/1 | 8,034,334
8,287,857 | Adoptive T-Cell Transfer After Lymphodepletion Promotes Tumor Regression | | 6/16/2010 | E-344-2002/0 | 7,514,529 | Peptide Mimotope Candidates for Otitis Media Vaccine | | 6/15/2010 | E-194-2000/0 | 7,897,152
8,318,177
8,460,675 | Methods and Compositions of Viral Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and AIDS | | 6/15/2010 | E-233-2000/0 | 7,052,907 | Adult Human Dental Pulp Stem Cells in vitro and in vivo | | 6/15/2010 | E-171-1994/0 | 5,780,589 | Application of Highly Potent and Ultraselective delta Opioidmimetic Peptide Antagonists for Biochemical, Pharmacological, Clinical and Therapeutic Studies | | 6/15/2010 | E-159-1996/0 | | Formation Of Human Bone In Vivo | | 6/15/2010 | E-218-1997/0 | 6,068,844 | The Application Of Induction Tolerance By Oral Feeding Of Myelin Basic Protein To The Generation Of Increased Resistance To Stroke | | 6/15/2010 | E-050-1998/0 | 6,153,421
7,201,911
7,846,454 | Cloned Genomes Of Infectious Hepatitis C Virus And Uses Thereof | | 6/15/2010 | E-141-2000/0 | 7,153,882
7,786,162
8,258,172 | Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof | | 6/15/2010 | E-215-2001/0 | 7,666,674 | Use of Sterically Stabilized Cationic Liposomes to Efficiently Deliver CpG Oligonucleotides in vivo | | 6/15/2010 | E-218-2001/0 | 7,514,414
8,227,438 | Identification of DNA Sequence Motifs that Suppress the Immune Response to CpG DNA |
|
| Back |
|
|
|
|
|
|